IQVIA(IQV)

DURHAM, NCCRO (Contract Research)1 H-1B visas (FY2023)

Focus: IQVIA is a global Contract Research Organization (CRO) and data analytics powerhouse serving the pharmaceutical and life sciences industry with 93,000 employees. The company operates at massive scale as a critical infrastructure provider conducting clinical trials, managing real-world data, and enabling drug development across the entire industry.

Profile data last refreshed 17h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

93,000

Open Jobs

About IQVIA

AI assessmentNot Hiring

No open roles listed right now. Follow IQVIA to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$15.0B

Pipeline & Clinical Trials

Online survey

Huntington's Disease

N/A

Clinical Trials (1)

NCT03628235HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

N/A

Help build intelligence for IQVIA

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Massive scale and stability: $15.0B FY2025 revenue with 5% YoY growth and $1.4B net income demonstrates financial fortress that supports career longevity
AI transformation leadership: IQVIA.ai launch with NVIDIA (April 2026) positions early adopters in cutting-edge drug development technology adopted by 19 of 20 top pharma companies
Exposure to entire pharma pipeline: Access to 30+ clinical programs spanning Phase 1-4 across oncology, immunology, infectious disease, and rare diseases provides unparalleled industry visibility

Watch Out For

CRO volatility: Career advancement and projects depend on pharma client spend cycles and clinical trial portfolio health, creating unpredictability despite company financial strength
Limited drug ownership: Unlike pharma companies, IQVIA runs trials for others' assets rather than owning marketed products, which may limit certain career trajectories in drug development

Generated by Claude from IQVIA's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Cancer treatment with tyrosine kinase inhibitors

Cancer

N/A

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treate

Breast Cancer

N/A

Clinical Trials (1)

NCT05599334A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

N/A

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

Parkinson's Disease

N/A

Clinical Trials (1)

NCT03994328An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

N/A

Anifrolumab Pregnancy Study

Systemic Lupus Erythematosus

N/A

Medical Device Iniettabile Ginocchio

the Treatment of Knee Osteoarthritis

N/A

Clinical Trials (1)

NCT05925595Intra-articular Administration of Med Device Made of Biological Vegetal Matrix for the Treatment of Knee Osteoarthritis

N/A

Out-of-specification obecabtagene autoleucel

Lymphoblastic Leukemia, Acute, Adult

N/A

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

Depression - Major Depressive Disorder

N/A

Clinical Trials (1)

NCT07377682Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

N/A

1-lead ECG

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT04247581ECG App Algorithms Clinical Validation Study

N/A

Blood collection

Malaria

N/A

Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry

Hepatocellular Carcinoma

N/A

Clinical Trials (1)

NCT03233360Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry

N/A

Maintenance of OAC in surgery of BPH by PVP.

Benign Prostatic Hyperplasia

N/A

Clinical Trials (1)

NCT03297281Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

N/A

LAmbre Occluder

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT03666780Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

N/A

Watchman FLX

Non-valvular Atrial Fibrillation

N/A

Clinical Trials (1)

NCT02654470Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

N/A

A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

Metastatic Non-small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT05546905A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

N/A

Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe

Degenerative Joint Disease of Hip

N/A

Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active

Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus

N/A

Cenobamate in Adults With Focal-Onset Seizures

Epilepsy

N/A

Clinical Trials (1)

NCT05859854Cenobamate in Adults With Focal-Onset Seizures

N/A

No Intervention: Observational Cohort

Intermittent Catheterization

N/A

Clinical Trials (1)

NCT07475468CP382 - Intermittent Catheter (IC) PRO Panel Plan

N/A

Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glom

Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate From Digital Retinal Images

N/A

Sentinel lymph node identification

Breast Cancer

N/A

Clinical Trials (1)

NCT06024213A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.

N/A

Colilen IBS

Irritable Bowel Syndrome

N/A

Clinical Trials (1)

NCT05016024Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.

N/A

Observational Cohort Study on the Use of Parenteral Nutrition and Clinical Outcomes in Adult Critica

Critical Illness

N/A

WB001

Postpartum Depression

N/A

Clinical Trials (1)

NCT05551195[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

N/A

1-Lead ECG

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT03492554Electrocardiogram Clinical Validation Study

N/A

Lenodiar Pediatric

Chronic Diarrhoea of Infants and/or Young Children

N/A

Clinical Trials (1)

NCT05904938Oral Administration of Actitan-F in Paediatric Diarrhoea

N/A

TOUCH® CMC 1 Prosthesis

Osteoarthritis Thumb

N/A

Clinical Trials (1)

NCT07405983TOUCH® CMC 1 New Enrollment US Study

N/A

ELECTROCARDIOGRAM

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT04699812Atrial Fibrillation Algorithms Clinical Validation Study

N/A

Interview

Fabry Disease

N/A

Carotid artery stenting with Neuroguard IEP System

Carotid Artery Stenosis

N/A

Clinical Trials (1)

NCT04201132Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System

N/A

Multi Pulse Therapy as delivered from the Cardialen External Stimulation System

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT05055921MultiPulse Therapy (MPT) for AF (US)

N/A

T-Detect Lyme

Lyme Disease

N/A

Clinical Trials (1)

NCT04422314ImmuneSense Lyme Study

N/A

Registry for Patients With X-Linked Hypophosphatemia

X-Linked Hypophosphatemia

N/A

Clinical Trials (1)

NCT03193476Registry for Patients With X-Linked Hypophosphatemia

N/A

transcatheter pulmonary valve implantation

Right Ventricular Outflow Tract Dysfunction

N/A

Clinical Trials (1)

NCT05835349Observational Study of Venus P-Valve

N/A

Tezepelumab

Cardiovascular Events

N/A

A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT06412250A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)

N/A

Cenobamate

Focal Epilepsy With and Without Secondary Generalization

N/A

Clinical Trials (1)

NCT06716801Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

N/A

Apple Software

Hearing

N/A

Clinical Trials (1)

NCT05872035Smartphone Enabled Hearing Study

N/A

eRAPID online symptom monitoring in lung cancer

Thoracic Cancer

N/A

Clinical Trials (1)

NCT04324437eRAPID: Online Symptom Reporting in Lung Cancer

N/A

Nutrition Insights Day Asia

Nutritional Status

N/A

trans catheter heart valve replacement

Pulmonary Regurgitation

N/A

Clinical Trials (1)

NCT02846753Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts

N/A

Observational test

Malnutrition

N/A

Control 1st age starter infant formula

Healthy Infants

N/A

Clinical Trials (1)

NCT06073652Starter Infant Formula With Synbiotics

N/A

FlexHD® Pliable

Implant Based Breast Reconstruction

N/A

Clinical Trials (1)

NCT06797258FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

N/A

US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

Hairy Cell Leukemia

N/A

SELUTION SLR 014 DEB

Coronary Restenosis

N/A

New Infant Formula

Weight Gain

N/A

Clinical Trials (1)

NCT05508750Growth and Safety Clinical Trial on a New Infant Formula

N/A

Multi Pulse Therapy

Atrial Fibrillation, Paroxysmal

N/A

Clinical Trials (1)

NCT04206917MultiPulse Therapy (MPT) for AF

N/A

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

Bladder Cancer

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 91 clinical trials

Top TAs: Oncology, Cardiovascular, Neurology

H-1B (2023): 1 approval

Publications: 45 in PubMed

SEC Filings: 2 available

Therapeutic Area Focus

16 pipeline

9 pipeline

8 pipeline

7 pipeline

7 pipeline

Financials (FY2025)

Revenue

$15.0B4%

Net Income

$1.4B

Cash

$1.7B

Employees

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Adult patient and caregiver perspectives on the impact of NF1-PN: Insights from a US qualitative survey.

Neuro-oncology advances

2026

PMID:41847169

Enhancing ICU Nurse Redeployment Practices: A Qualitative Improvement Study of Support Interventions.

Gastroenterology

2 pipeline

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

IQVIA(IQV)

About IQVIA

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Recent News · IQVIA(10)

Open Jobs (0)

Financials (FY2025)

Hiring Trend

Visa Sponsorship

Research Publications(10)